Shoulder-arm morbidity in patients with sentinel node biopsy and complete axillary dissection - data from a prospective randomised trial

European Journal of Surgical Oncology

Volumn 35, Issue 7, 2009, Pages 696-701

  Helms, G ^a   Kuhn T ^b   Moser, L ^c   Remmel, E ^a   Kreienberg, R ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b KLINIKUM ESSLINGEN   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Breast cancer; Prospective trial; Sentinel node biopsy; Shoulder arm morbidity

Indexed keywords

ARM EDEMA; ARM MOVEMENT; ARM SWELLING; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MORBIDITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SHOULDER; SURGICAL TECHNIQUE;

ARM; AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHEDEMA; MORBIDITY; MUSCLE STRENGTH; PAIN; RANGE OF MOTION, ARTICULAR; SENTINEL LYMPH NODE BIOPSY; SHOULDER; SHOULDER JOINT;

EID: 67349142044     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2008.06.013     Document Type: Article

References (32)

1. Silva O.E., and Zurrida S. Breast cancer: a practical guide (2000), Elsevier, Oxford
2. Kuehn T., Klaus W., Darsow M., et al. Long-term morbidity following axillary dissection in breast cancer patients - clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64 (2000) 275-286
3. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer. New Engl J Med 339 14 (1998) 941-946
4. McMasters K., Tuttle T., Carlson D.J., et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multiinstitutional practice when optimal technique is used. J Clin Oncol 18 13 (2000) 2560-2566
5. Tafra L., Lannin D.R., Swanson M.S., et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 233 1 (2001) 51-59
6. Bergkvist L., Frisell J., Liljegren G., Celebioglu F., Damm S., and Thorn M. Multicentre study of detection and false-negative rates in sentinel node biopsy for breast cancer. Br J Surg 88 12 (2001) 1644-1648
7. Kuehn T., Vogl F.D., Helms G., et al. Sentinel-node biopsy for axillary staging in breast cancer: results from a large prospective German multi-institutional trial. Eur J Surg Oncol 30 3 (2004) 252-259
8. Kuehn T., Klauss W., Darsow M., et al. A new score for the assessment of postsurgery morbidity following axillary surgery. Breast Cancer Res Treat 64 1 (2000) 37
9. Hack T.F., Cohen L., Katz J., Robson L.S., and Goss P. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17 (1999) 143-149
10. Ververs J.M.M.A., Roumen R.M., Vingerhoets A.J.J.M., et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 37 (2001) 991-999
11. Schrenk P., Rieger R., Shamiyeh A., and Wayand W. Morbidity following sentinel node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88 3 (2000) 608-614
12. Fleissig A., Fallowfield L.J., Langridge C.I., et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95 3 (2006) 279-293
13. Temple L.K., Baron R., Cody III H.S., et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 9 7 (2002) 654-662
14. Rietman J.S., Dijkstra P.U., Geertzen J.H.B., et al. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11 (2004) 1018-1024
15. Rönkä R., Smitten K.V., Tasmuth T., and Leidenius M. One-year morbidity after sentinel node biopsy and breast surgery. Breast 14 (2005) 28-36
16. Leidenius M., Leppanen E., Krogerus L., and von Smitten K. Motion restriction and axillary web syndrome after sentinel node biopsy and axillary clearance in breast cancer. Am J Surg 185 2 (2003) 127-130
17. Mansel R., Fallowfield L.J., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98 9 (2006) 599-609
18. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23 19 (2005) 4312-3421
19. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node-biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 6 (2003) 546-553
20. Blanchard D.K., Donohue J.H., Reynolds C., and Grant C.S. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138 (2003) 482-488
21. Burak W.E., Hollenbeck S.T., Zervos E.E., Hock K.L., Kemp L.C., and Young D.C. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183 1 (2002) 23-27
22. Fallowfield L.J., Johnson L., Jenkins V.A., Newcombe R.G., and Mansel R. Impact of sentinel node biopsy on quality of life in the ALMANAC trial. Breast Cancer Res Treat 88 Suppl 1 (2004) S77
23. Haid A., Kuehn T., Konstantiniuk P., et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 28 7 (2002) 705-710
24. Langer I., Guller U., Berclaz G., et al. Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients. Ann Surg 245 3 (2007) 452-461
25. Peintinger F., Reitsamer R., Stranzl H., and Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel node biopsy in breast cancer patients. Br J Cancer 89 (2003) 648-652
26. Rietman J.S., Geertzen J.H.B., Hoekstra J.H., et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32 2 (2006) 148-152
27. Schijven M.P., Vingerhoets A.J.J.M., Rutten H.J.T., et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29 (2003) 341-350
28. Schulze T., Mucke J., Markwardt J., Schlag P., and Bembenek A. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 93 2 (2006) 109-119
29. Swenson K.K., Nissen M.J., Ceronsky C., Swenson L., Lee M.W., and Tuttle T.M. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9 8 (2002) 745-753
30. Husted Madsen A, Haugaard K, Soerensen J, et al. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Breast 17 2 (2008) 138-147
31. Armer J., Fu M.R., Wainstock J.M., Zagar E., and Jacobs L.K. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy. Lymphology 37 2 (2004) 73-91
32. Sener S.F., Winchester D.J., Martz C.H., et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92 4 (2001) 748-752